Geneos Wealth Management’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Geneos Wealth Management’s Portfolio BATRK Stock Details BATRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,007	Closed	-$49K	–	2049
2022 Q2	$49K	Hold	2,007	–	–	﹤0.01%	1291
2022 Q1	$56K	Hold	2,007	–	–	﹤0.01%	1328
2021 Q4	$56K	Hold	2,007	–	–	﹤0.01%	1425
2021 Q3	$54K	Hold	2,007	–	–	﹤0.01%	1447
2021 Q2	$55K	Hold	2,007	–	–	﹤0.01%	1425
2021 Q1	$55K	Hold	2,007	–	–	﹤0.01%	1573
2020 Q4	$57K	Buy	+2,007	New	+$47.3K	﹤0.01%	1393
2018 Q1	–	Sell	-1,007	Closed	-$22K	–	2172
2017 Q4	$22K	Hold	1,007	–	–	﹤0.01%	1339
2017 Q3	$25K	Hold	1,007	–	–	﹤0.01%	1237
2017 Q2	$24K	Hold	1,007	–	–	﹤0.01%	1197
2017 Q1	$23K	Hold	1,007	–	–	﹤0.01%	1185
2016 Q4	$20K	Sell	1,007 -2	-0.2%	-$37	﹤0.01%	1178
2016 Q3	$17K	Buy	+1,009	New	+$16.4K	﹤0.01%	1180

Other funds holding BATRK

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Geneos Wealth Management's BATRK Position: Q3 2022 in Review

Geneos Wealth Management sold out of Atlanta Braves Holdings Series B (BATRK) in Q3 2022, closing a stake of 2,007 shares — an estimated $49K sold.

Geneos Wealth Management first reported a position in BATRK in Q3 2016 and held it in 13 quarters. The position peaked at $57K in Q4 2020. 177 funds tracked by Wall St. Rank hold BATRK as of Q3 2022.

Geneos Wealth Management reported no remaining Atlanta Braves Holdings Series B position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 2,007 Atlanta Braves Holdings Series B shares in Q3 2022, an estimated $49K.
Geneos Wealth Management first reported a position in Atlanta Braves Holdings Series B in Q3 2016 and held it in 13 quarters.
Geneos Wealth Management's Atlanta Braves Holdings Series B position peaked at $57K in Q4 2020.
177 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.